GENUS PHARMACEUTICALS HOLDINGS LIMITED
Get an alert when GENUS PHARMACEUTICALS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£16m
+2.7% highest in 3 filed years
Employees
—
Average over period
Profit before tax
£6.6m
-53% lowest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £1,877,000 | £8,557,000 | £18,298,000 | +113.8% | |
| Operating profit | £609,000 | £1,950,000 | £551,000 | -71.7% | |
| Profit before tax | £9,609,000 | £13,950,000 | £6,551,000 | -53% | |
| Net profit | £9,466,000 | £13,463,000 | £6,413,000 | -52.4% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £13,861,000 | £15,324,000 | £15,737,000 | +2.7% | |
| Net assets | £13,861,000 | £15,324,000 | £15,737,000 | +2.7% | |
| Equity | £13,861,000 | £15,324,000 | £15,737,000 | +2.7% | |
| Average employees | 2 | 2 | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £474,000 | £792,000 | £958,000 | +21% | |
| Directors' pension contributions | £29,000 | £28,420 | £16,850 | -40.7% | |
| Highest paid director | £152,000 | £540,541 | £666,537 | +23.3% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 32.4% | 22.8% | 3.0% | |
| Net margin | — | 157.3% | 35.0% | |
| Return on capital employed | 4.4% | 12.7% | 3.5% | |
| Gearing (liabilities / total assets) | 71.0% | 68.9% | 70.0% | |
| Current ratio | 0.24x | 0.28x | 0.35x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- GENUS PHARMACEUTICALS HOLDINGS LIMITED 2004-06-30 → present
- SCHEIN PHARMACEUTICAL HOLDINGS UK LIMITED 1999-09-10 → 2004-06-30
- SCHEIN PHARMACEUTICAL UK LIMITED 1999-01-15 → 1999-09-10
- FIMTON LIMITED 1998-08-21 → 1999-01-15
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have assessed the risk of the intercompany balances being fully recalled in the twelve month period from approval of the balance sheet to be low. There is also a letter of support in place for these balances such that these balances are not due for repayment within this twelve month period. Therefore the Directors have concluded that the going concern assumption remains appropriate.”
Group structure
- GENUS PHARMACEUTICALS HOLDINGS LIMITED · parent
- Genus Pharmaceuticals Limited 100%
- Britannia Pharmaceuticals Limited 100%
Significant events
- “During the year, the ultimate shareholders of the Company's intermediate parent, Stada Arzneimittel AG agreed the sale of a majority stake in Stada Arzneimittel AG to CapVest Partners LLP. The transaction completed on 31 March 2026.”
- “After the year end, the Company announced a reorganisation of its operations. The reorganisation will involve changes to the Company's organisational structure and operational processes and is intended to support the long-term strategic objectives of the business.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 34 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COLLETT, James David | Director | 2023-09-01 | Oct 1975 | British |
| SHAW, Craig Richard | Director | 2025-11-03 | Jan 1977 | British |
Show 34 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ADAMS, Geoffrey Martin | Secretary | 2016-05-01 | 2018-04-06 |
| ALPIN, Janet | Secretary | 2015-06-01 | 2016-05-01 |
| BLYTHE, Edwin Charles | Secretary | 2018-04-06 | 2023-01-31 |
| FEVERMAN, Paul | Secretary | 1999-10-15 | 2000-08-08 |
| FUNSTEN, Robert C | Secretary | 2000-12-07 | 2002-05-10 |
| GORE-STRACHAN, Evelyn | Secretary | 2014-06-30 | 2015-06-01 |
| HANLON, James | Secretary | 2006-04-05 | 2006-12-13 |
| HEYWOOD, Kathryn Maria | Secretary | 2023-01-31 | 2023-01-31 |
| SALMOND, Hamish George | Secretary | 1999-10-15 | 2004-06-04 |
| WATERS, Gary | Secretary | 1998-08-27 | 1999-10-15 |
| WRIGHT, Philip John | Secretary | 2006-12-13 | 2014-06-30 |
| COMBINED SECRETARIAL SERVICES LIMITED | Corporate Nominee Secretary | 1998-08-21 | 1998-08-27 |
| ADAMS, Geoffrey Martin | Director | 2015-06-01 | 2018-04-06 |
| ASHRAFI, Dariush | Director | 1998-08-27 | 2000-08-08 |
| BALLARD, Peter Gavin | Director | 2004-06-22 | 2013-10-15 |
| BLYTHE, Edwin Charles | Director | 2022-10-01 | 2023-01-31 |
| BRIERLEY, Charles Ashley | Director | 2018-12-31 | 2019-12-02 |
| CHAO, Allen Yuten | Director | 2000-12-07 | 2003-03-10 |
| DARROCH, Colin | Director | 1999-10-15 | 2001-03-16 |
| GEORGE, Dieno | Director | 2017-10-27 | 2018-12-31 |
| HANLON, James Anthony | Director | 2003-03-04 | 2010-05-17 |
| HEYWOOD, Kathryn Maria | Director | 2023-01-31 | 2023-09-01 |
| NIEMANN, Peter, Dipl Ing | Director | 2003-03-04 | 2005-04-21 |
| O RIORDAN, Rory Walter | Director | 2003-03-04 | 2005-04-21 |
| O' RIORDAN, Rory | Director | 2005-12-13 | 2010-05-17 |
| SCARLETT-SMITH, Roger Lidderdale | Director | 2019-12-02 | 2022-10-01 |
| SLEGERS, Luc Maurice Godelieva | Director | 2005-12-13 | 2017-10-31 |
| SPERBER, Martin | Director | 1999-10-15 | 2000-08-08 |
| STEPHENSON, Nigel David | Director | 2023-08-01 | 2025-07-31 |
| SYDOW, Volker | Director | 2025-06-17 | 2025-11-03 |
| WATERS, Gary | Director | 1998-08-27 | 2001-03-31 |
| WRIGHT, Philip John | Director | 2009-04-17 | 2010-05-17 |
| COMBINED NOMINEES LIMITED | Corporate Nominee Director | 1998-08-21 | 1998-08-27 |
| COMBINED SECRETARIAL SERVICES LIMITED | Corporate Nominee Director | 1998-08-21 | 1998-08-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Stada Uk Holdings Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-06-30 | Active |
Filing timeline
Last 20 of 158 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-08-07 | AA | accounts | Accounts with accounts type full | |
| 2025-11-05 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-07 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-08-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-20 | AP01 | officers | Appoint person director company with name date | |
| 2025-06-04 | AA | accounts | Accounts with accounts type full | |
| 2025-05-08 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-03-12 | CH01 | officers | Change person director company with change date | |
| 2025-01-15 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-13 | AA | accounts | Accounts with accounts type full | |
| 2024-08-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-06-18 | CH01 | officers | Change person director company with change date | |
| 2023-11-10 | CH01 | officers | Change person director company with change date | |
| 2023-09-06 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-06 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-29 | AA | accounts | Accounts with accounts type small |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.